Working… Menu

The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00584389
Recruitment Status : Terminated (Suspension of licence for rimonabant by European Medicines Agency)
First Posted : January 2, 2008
Last Update Posted : April 19, 2010
European Foundation for the Study of Diabetes
Royal Surrey County Hospital NHS Foundation Trust
Information provided by:
University of Surrey

No Study Results Posted on for this Study
Recruitment Status : Terminated
Estimated Primary Completion Date : April 2009
Estimated Study Completion Date : May 2010